CT
Crossbow Therapeutics, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$30.3Msold at filing
Total offering$80M$49.8M still open
Investors in the raise17count reported to the SEC
FiledSep 30, 2025first sale Sep 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alexander NolteExecutive Officer
Alexandra CantleyDirector
Dmitri WiederschainExecutive Officer
Sakae AsanumaDirector
Charles BaumDirector
Briggs MorrisonExecutive Officer, Director, Promoter
Irena MelnikovaDirector
Alon LazarusDirector
Todd FoleyDirector
Executive officers, directors and promoters as listed on the Form D.